CD7 and leukemia: Indeed we have found that 3/3 tested short term engrafting T-ALLs contain a predominant genetically defined clone endowed with xenograft leukemia development capacity that segregates with CD7+/CD34+ and CD7+/CD34− cell fractions, although the latter fraction was poorer in such function.